619 related articles for article (PubMed ID: 26764282)
21. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases.
Chi A; Jang SY; Welsh JS; Nguyen NP; Ong E; Gobar L; Komaki R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):856-62. PubMed ID: 21255942
[TBL] [Abstract][Full Text] [Related]
22. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
24. Investigation of simple IMRT delivery techniques for non-small cell lung cancer patients with respiratory motion using 4DCT.
Reitz B; Parda DS; Colonias A; Lee V; Miften M
Med Dosim; 2009; 34(2):158-69. PubMed ID: 19410146
[TBL] [Abstract][Full Text] [Related]
25. Dynamic hybrid-phase computed tomography simulation in lung stereotactic body radiotherapy: A feasibility study.
Hwang JM; Hung JY; Chang YK; Chang SM; Wang YN; Lin CS; Chang CS
Med Dosim; 2022 Summer; 47(2):136-141. PubMed ID: 34987001
[TBL] [Abstract][Full Text] [Related]
26. Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.
Wilke L; Moustakis C; Blanck O; Albers D; Albrecht C; Avcu Y; Boucenna R; Buchauer K; Etzelstorfer T; Henkenberens C; Jeller D; Jurianz K; Kornhuber C; Kretschmer M; Lotze S; Meier K; Pemler P; Riegler A; Röser A; Schmidhalter D; Spruijt KH; Surber G; Vallet V; Wiehle R; Willner J; Winkler P; Wittig A; Guckenberger M; Tanadini-Lang S
Strahlenther Onkol; 2021 Sep; 197(9):836-846. PubMed ID: 34196725
[TBL] [Abstract][Full Text] [Related]
27. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
[TBL] [Abstract][Full Text] [Related]
28. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
29. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.
Sonke JJ; Rossi M; Wolthaus J; van Herk M; Damen E; Belderbos J
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):567-74. PubMed ID: 19046825
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric evaluation of compensator intensity modulation-based stereotactic body radiotherapy for Stage I non-small-cell lung cancer.
Tajima Y; Nakayama H; Itonaga T; Shiraishi S; Okubo M; Mikami R; Sugahara S; Tokuuye K
Br J Radiol; 2015 Aug; 88(1052):20150122. PubMed ID: 25996577
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric Study of Deep Learning-Guided ITV Prediction in Cone-beam CT for Lung Stereotactic Body Radiotherapy.
Zhang S; Lv B; Zheng X; Li Y; Ge W; Zhang L; Mo F; Qiu J
Front Public Health; 2022; 10():860135. PubMed ID: 35392465
[TBL] [Abstract][Full Text] [Related]
32. Craniocaudal safety margin calculation based on interfractional changes in tumor motion in lung SBRT assessed with an EPID in cine mode.
Ueda Y; Miyazaki M; Nishiyama K; Suzuki O; Tsujii K; Miyagi K
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1064-9. PubMed ID: 22245190
[TBL] [Abstract][Full Text] [Related]
33. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
[TBL] [Abstract][Full Text] [Related]
34. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.
Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716
[TBL] [Abstract][Full Text] [Related]
35. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
[TBL] [Abstract][Full Text] [Related]
36. High-dose-rate Three-dimensional Conformal Radiotherapy Combined with Active Breathing Control for Stereotactic Body Radiotherapy of Early-stage Non-small-cell Lung Cancer.
Wang R; Yin Y; Qin Y; Yu J
Technol Cancer Res Treat; 2015 Dec; 14(6):677-82. PubMed ID: 24988055
[TBL] [Abstract][Full Text] [Related]
37. Impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy.
Atallah S; Cho BC; Allibhai Z; Taremi M; Giuliani M; Le LW; Brade A; Sun A; Bezjak A; Hope AJ
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):532-8. PubMed ID: 24929163
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Various Dose Normalization Strategies When Implementing Linear Boltzmann Transport Equation Dose Calculation for Lung Stereotactic Body Radiation Therapy Planning.
Erickson BG; Ackerson BG; Kelsey CR; Yin FF; Adamson J; Cui Y
Pract Radiat Oncol; 2022; 12(5):446-456. PubMed ID: 35219882
[TBL] [Abstract][Full Text] [Related]
39. Forcing lateral electron disequilibrium to spare lung tissue: a novel technique for stereotactic body radiation therapy of lung cancer.
Disher B; Hajdok G; Gaede S; Mulligan M; Battista JJ
Phys Med Biol; 2013 Oct; 58(19):6641-62. PubMed ID: 24018569
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.
Fritz P; Kraus HJ; Blaschke T; Mühlnickel W; Strauch K; Engel-Riedel W; Chemaissani A; Stoelben E
Lung Cancer; 2008 May; 60(2):193-9. PubMed ID: 18045732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
